# | Title | Journal | Year | Citations |
---|
1 | KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD) | Kidney International Supplements | 2017 | 1,214 |
2 | Chapter 1: Definition and classification of CKD | Kidney International Supplements | 2013 | 861 |
3 | Section 2: AKI Definition | Kidney International Supplements | 2012 | 677 |
4 | Epidemiology of chronic kidney disease: an update 2022 | Kidney International Supplements | 2022 | 596 |
5 | Risk factors for chronic kidney disease: an update | Kidney International Supplements | 2013 | 389 |
6 | Summary of Recommendation Statements | Kidney International Supplements | 2013 | 370 |
7 | United States Renal Data System public health surveillance of chronic kidney disease and end-stage renal disease | Kidney International Supplements | 2015 | 335 |
8 | Summary of Recommendation Statements | Kidney International Supplements | 2012 | 254 |
9 | Wnt/β-catenin signaling and kidney fibrosis | Kidney International Supplements | 2014 | 221 |
10 | Diagnosis of diabetic kidney disease: state of the art and future perspective | Kidney International Supplements | 2018 | 202 |
11 | Overview of the cellular and molecular basis of kidney fibrosis | Kidney International Supplements | 2014 | 193 |
12 | Macrophages promote renal fibrosis through direct and indirect mechanisms | Kidney International Supplements | 2014 | 177 |
13 | Chapter 2: Definition, identification, and prediction of CKD progression | Kidney International Supplements | 2013 | 156 |
14 | Reducing major risk factors for chronic kidney disease | Kidney International Supplements | 2017 | 155 |
15 | KDIGO 2018 Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease | Kidney International Supplements | 2018 | 141 |
16 | Global nephrology workforce: gaps and opportunities toward a sustainable kidney care system | Kidney International Supplements | 2018 | 123 |
17 | Chapter 10: Immunoglobulin A nephropathy | Kidney International Supplements | 2012 | 122 |
18 | Chapter 3: Management of progression and complications of CKD | Kidney International Supplements | 2013 | 121 |
19 | Current status of end-stage renal disease care in India and Pakistan | Kidney International Supplements | 2013 | 112 |
20 | Complications of chronic kidney disease: current state, knowledge gaps, and strategy for action | Kidney International Supplements | 2017 | 106 |
21 | Chapter 7: Idiopathic membranous nephropathy | Kidney International Supplements | 2012 | 103 |
22 | Obesity, oxidative stress, and fibrosis in chronic kidney disease | Kidney International Supplements | 2014 | 100 |
23 | Biology of stem cells: an overview | Kidney International Supplements | 2011 | 94 |
24 | Section 5: Dialysis Interventions for Treatment of AKI | Kidney International Supplements | 2012 | 92 |
25 | A phosphate-centric paradigm for pathophysiology and therapy of chronic kidney disease | Kidney International Supplements | 2013 | 85 |
26 | China Kidney Disease Network (CK-NET) 2015 Annual Data Report | Kidney International Supplements | 2019 | 83 |
27 | Global access of patients with kidney disease to health technologies and medications: findings from the Global Kidney Health Atlas project | Kidney International Supplements | 2018 | 82 |
28 | Primary proximal tubule injury leads to epithelial cell cycle arrest, fibrosis, vascular rarefaction, and glomerulosclerosis | Kidney International Supplements | 2014 | 78 |
29 | Kidney disease and vitamin D levels: 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, and VDR activation | Kidney International Supplements | 2011 | 77 |
30 | Key fibrogenic mediators: old players. Renin–angiotensin system | Kidney International Supplements | 2014 | 77 |
31 | What is the best way to measure renal fibrosis?: A pathologist’s perspective | Kidney International Supplements | 2014 | 76 |
32 | Hypoxia-inducible factor–prolyl hydroxylase inhibitors in the treatment of anemia of chronic kidney disease | Kidney International Supplements | 2021 | 75 |
33 | Work Group Membership | Kidney International Supplements | 2012 | 74 |
34 | Renal registry in Hong Kong—the first 20 years | Kidney International Supplements | 2015 | 74 |
35 | Chapter 3: Steroid-sensitive nephrotic syndrome in children | Kidney International Supplements | 2012 | 70 |
36 | Uremic osteoporosis | Kidney International Supplements | 2013 | 70 |
37 | Toll-like receptor activation: from renal inflammation to fibrosis | Kidney International Supplements | 2014 | 70 |
38 | Japanese society for dialysis therapy renal data registry—a window through which we can view the details of Japanese dialysis population | Kidney International Supplements | 2015 | 70 |
39 | China Kidney Disease Network (CK-NET) 2016 Annual Data Report | Kidney International Supplements | 2020 | 70 |
40 | Training nephrologists from developing countries: does it have a positive impact? | Kidney International Supplements | 2012 | 68 |
41 | Chapter 1: Diagnosis and evaluation of anemia in CKD | Kidney International Supplements | 2012 | 68 |
42 | Hypoxia and fibrosis in chronic kidney disease: crossing at pericytes | Kidney International Supplements | 2014 | 67 |
43 | Australia and New Zealand Dialysis and Transplant Registry | Kidney International Supplements | 2015 | 65 |
44 | Chapter 12: Lupus nephritis | Kidney International Supplements | 2012 | 64 |
45 | Chapter 11: Henoch-Schönlein purpura nephritis | Kidney International Supplements | 2012 | 64 |
46 | Cardiovascular and other effects of salt consumption | Kidney International Supplements | 2013 | 64 |
47 | AOPPs and the progression of kidney disease | Kidney International Supplements | 2014 | 61 |
48 | The dysfunctional endothelium in CKD and in cardiovascular disease: mapping the origin(s) of cardiovascular problems in CKD and of kidney disease in cardiovascular conditions for a research agenda | Kidney International Supplements | 2011 | 57 |
49 | Towards prevention of chronic kidney disease in Nigeria: a community-based study in Southeast Nigeria | Kidney International Supplements | 2013 | 57 |
50 | The FOXD1 lineage of kidney perivascular cells and myofibroblasts: functions and responses to injury | Kidney International Supplements | 2014 | 57 |